Cargando…

Resistance to antineoplastic drugs

Detalles Bibliográficos
Autor principal:	Twentyman, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971324/

Ejemplares similares

Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979)

Drug Resistance in Oncology
por: Twentyman, P.R.
Publicado: (1994)

Antineoplastic and Immunosuppressive Agents—Part 1
por: Lajtha, L. G.
Publicado: (1975)

The reversal of antineoplastic drug resistance in cancer cells by β-elemene
por: Zhang, Guan-Nan, et al.
Publicado: (2015)

Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020)

Tumor targeting using liposomal antineoplastic drugs
por: Huwyler, Jörg, et al.
Publicado: (2008)

Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
por: Ralph, Stephen John
Publicado: (2008)

Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery
por: Petrella, Francesco, et al.
Publicado: (2017)

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview
por: Roger, Inés, et al.
Publicado: (2023)

A Dictionary of Modern Medicine
por: Twentyman, P.R.
Publicado: (1993)

The Basic Science of Oncology. 2nd Edition
por: Twentyman, P.R.
Publicado: (1993)

Ototoxic effects of antineoplastic drugs: a systematic review
por: Patatt, Fernanda Soares Aurélio, et al.
Publicado: (2021)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
por: Rattner, Jodi, et al.
Publicado: (2017)

Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2019)

Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
por: Papanagnou, Panagiota, et al.
Publicado: (2016)

Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs
por: Todorov, Lozan, et al.
Publicado: (2023)

Electrolyte Disorders Induced by Antineoplastic Drugs
por: Verzicco, Ignazio, et al.
Publicado: (2020)

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022)

Ocular complications of antineoplastic therapies
por: Bader, Abbas, et al.
Publicado: (2023)

Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment
por: Qu, Yidi, et al.
Publicado: (2019)

Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells
por: Eschenburg, Georg, et al.
Publicado: (2014)

Standardization of the infusion sequence of antineoplastic drugs used in the treatment of breast and colorectal cancers
por: da Silva, Amanda Alves, et al.
Publicado: (2018)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Extravasation of Antineoplastic Agents: Prevention and Treatments
por: Boschi, Rita, et al.
Publicado: (2012)

Melatonin’s Antineoplastic Potential Against Glioblastoma
por: Moretti, Enrico, et al.
Publicado: (2020)

An Overview of the Potential Antineoplastic Effects of Casticin
por: Ramchandani, Shanaya, et al.
Publicado: (2020)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
por: Layton, Jodi L., et al.
Publicado: (2018)

Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review
por: Hsieh, Cho-Hsun, et al.
Publicado: (2022)

Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data
por: Leso, Veruscka, et al.
Publicado: (2022)

Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs
por: Manthalkar, Laxmi, et al.
Publicado: (2022)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

Drug Resistance in Antimicrobial Therapy
por: Andriole, Vincent T.
Publicado: (1976)

Dental anomalies in children submitted to antineoplastic therapy
por: Carrillo, Camila Merida, et al.
Publicado: (2014)

Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic
por: Barnabei, Agnese, et al.
Publicado: (2022)

Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy
por: Chis, Adriana Aurelia, et al.
Publicado: (2022)

Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review
por: Alamri, Raghad D., et al.
Publicado: (2021)

Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs
por: Molinaro, Marilisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7qvn2828scklfr1mavolq12p77